BACKGROUND: There is a paucity of outcomes data for patients with lymph node metastasis from cutaneous squamous cell carcinoma of head and neck (SCCHN). METHODS: Patients from a tertiary care center with cutaneous SCCHN metastatic to parotid and or cervical lymph nodes were identified. Data were abstracted and analyzed using COX multivariate analysis. RESULTS: Fifty-one patients (47 men, and 4 women) with a median age of 73 years were identified. Eight patients (16%) had recurrent disease and 11 (22%) were immunosuppressed. Forty patients (71%) received adjuvant radiation therapy. Median overall survival was 23 months (range, 3-148 months). Recurrent disease was associated with higher risk of death (hazard ratio [HR], 2.7; 95% confidence interval [CI] 1.1-6.9) and radiation therapy with reduced risk (HR, 0.18; 95% CI, 0.06-0.54). CONCLUSION: Lymph node metastases from cutaneous SCCHN is associated with poor survival.
BACKGROUND: There is a paucity of outcomes data for patients with lymph node metastasis from cutaneous squamous cell carcinoma of head and neck (SCCHN). METHODS:Patients from a tertiary care center with cutaneous SCCHN metastatic to parotid and or cervical lymph nodes were identified. Data were abstracted and analyzed using COX multivariate analysis. RESULTS: Fifty-one patients (47 men, and 4 women) with a median age of 73 years were identified. Eight patients (16%) had recurrent disease and 11 (22%) were immunosuppressed. Forty patients (71%) received adjuvant radiation therapy. Median overall survival was 23 months (range, 3-148 months). Recurrent disease was associated with higher risk of death (hazard ratio [HR], 2.7; 95% confidence interval [CI] 1.1-6.9) and radiation therapy with reduced risk (HR, 0.18; 95% CI, 0.06-0.54). CONCLUSION: Lymph node metastases from cutaneous SCCHN is associated with poor survival.
Authors: Larissa Sweeny; Nichole R Dean; J Scott Magnuson; William R Carroll; Emily E Helman; Stephen O Hyde; Renee L Desmond; Eben L Rosenthal Journal: Head Neck Date: 2011-07-07 Impact factor: 3.147
Authors: Axel Sahovaler; Rohin J Krishnan; David H Yeh; Qi Zhou; David Palma; Kevin Fung; John Yoo; Anthony Nichols; S Danielle MacNeil Journal: JAMA Otolaryngol Head Neck Surg Date: 2019-04-01 Impact factor: 6.223
Authors: A J G Leus; M Frie; M S Haisma; J B Terra; B E C Plaat; R J H M Steenbakkers; G B Halmos; E Rácz Journal: J Eur Acad Dermatol Venereol Date: 2020-03-30 Impact factor: 6.166
Authors: Renata Ferrarotto; Moran Amit; Priyadharsini Nagarajan; M Laura Rubin; Ying Yuan; Diana Bell; Adel K El-Naggar; Jason M Johnson; William H Morrison; David I Rosenthal; Bonnie S Glisson; Faye M Johnson; Charles Lu; Frank E Mott; Bita Esmaeli; Eduardo M Diaz; Paul W Gidley; Ryan P Goepfert; Carol M Lewis; Randal S Weber; Jennifer A Wargo; Sreyashi Basu; Fei Duan; Shalini S Yadav; Padmanee Sharma; James P Allison; Jeffrey N Myers; Neil D Gross Journal: Clin Cancer Res Date: 2021-06-29 Impact factor: 12.531
Authors: Stephanie Flukes; Sallie Long; Shivangi Lohia; Christopher A Barker; Lara A Dunn; Jennifer Cracchiolo; Ian Ganly; Snehal Patel; Marc A Cohen Journal: OTO Open Date: 2021-01-08
Authors: Luke S McLean; Annette M Lim; Angela Webb; Karda Cavanagh; Alesha Thai; Matthew Magarey; Carly Fox; Stephen Kleid; Danny Rischin Journal: Front Oncol Date: 2022-01-18 Impact factor: 6.244